Air Liquide Expands Its Home Healthcare Business to Ireland
June 25 2015 - 10:35AM
Business Wire
Regulatory News:
Air Liquide (Paris:AI) is expanding its home healthcare
business in Europe with the acquisition of Baywater Healthcare
Ireland Limited, a major player in this activity in
Ireland.
On the Irish market for 30 years, Baywater Healthcare
Ireland Limited specializes in treating and
monitoring respiratory diseases in the patient's
home (oxygen therapy, continuous positive airway pressure
and non-invasive ventilation). Baywater Healthcare Ireland Limited
has 50 employees and cares for 10,000 patients, generating revenue
of more than €12 million in 2014.
This acquisition marks a new geographical
development for Air Liquide's home healthcare
business, with the extension of its services to Ireland. Air
Liquide will continue growing the company with the support of the
existing team.
Pascal Vinet, Vice-President, Healthcare Global
Operations and member of Air Liquide group’s Executive
Committee commented: "The acquisition of this company, which is
recognized for its expertise in the treatment of respiratory
diseases and for its culture of innovation, is part of Air
Liquide's growth strategy for the home healthcare business. It will
allow us to develop on a new growth market in Europe."
Air Liquide
Healthcare
supplies medical gases, home healthcare
services, hygiene products, medical equipment and specialty
ingredients.
In 2014, it served over 7,500
hospitals and 1,2 million patients at home throughout
the world.
The Group’s Healthcare business reached
€ 2,570 million in revenues in 2014, with the support of its
12,000 employees.
The Home
Healthcare Business
Air Liquide, European leader in home
healthcare, provides home healthcare services in compliance
with medical prescription for patients suffering from chronic
diseases such as COPD (Chronic Obstructive Pulmonary Disease),
sleep apnea and diabetes. These home healthcare services are being
developed in addition to hospital care, enabling patients to enjoy
better quality of life and local authorities to reduce costs. Home
healthcare represents 50% of Air Liquide's revenue in Healthcare
in 2014.
World leader in gases, technologies and services for Industry
and Health, Air Liquide is present in 80 countries with more than
50,000 employees and serves more than 2 million customers and
patients. Oxygen, nitrogen and hydrogen have been at the core of
the company’s activities since its creation in 1902. Air Liquide’s
ambition is to be the leader in its industry, delivering long-term
performance and acting responsibly.
Air Liquide ideas create value over the long term. At the core
of the company’s development are the commitment and constant
inventiveness of its people.
Air Liquide anticipates the challenges of its markets, invests
locally and globally, and delivers high-quality solutions to its
customers and patients, and the scientific community.
The company relies on competitiveness in its operations,
targeted investments in growing markets and innovation to deliver
profitable growth over the long-term.
Air Liquide’s revenues amounted to € 15.4 billion in 2014, and
its solutions that protect life and the environment represented
more than 40% of sales. Air Liquide is listed on the Paris Euronext
stock exchange (compartment A) and is a member of the CAC 40
and Dow Jones Euro Stoxx 50 indexes.
www.airliquide.comFollow us on Twitter
@AirLiquideGroup
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150625005519/en/
Air LiquideCorporate CommunicationsCaroline
Philips, +33 (0)1 40 62 50 84Anne Michaud, +33 (0)1 40 62 50
59orInvestor RelationsAude Rodriguez, +33 (0)1 40 62 57
08Louis Laffont, +33 (0)1 40 62 57 18orAir Liquide Healthcare
CommunicationsMuriel Doucet, +33(0)1 49 69 46 46
C3 AI (NYSE:AI)
Historical Stock Chart
From Jun 2024 to Jul 2024
C3 AI (NYSE:AI)
Historical Stock Chart
From Jul 2023 to Jul 2024